About
Zipdose formulation
Areas of Focus
Categories
Drug Delivery & FormulationMidwest
Team (4)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
0
As Collaborator
7
Total Enrollment
951
By Phase
PHASE2/PHASE3: 1PHASE2: 1PHASE1: 1PHASE3: 4
By Status
COMPLETED: 7
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Today
Hover over trial bars to see details
Recent Trials
NCT00414128Collaborator
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
PHASE2/PHASE3Completed
140 participants
Started: Mar 31, 2007 · Completed: Feb 28, 2013
NCT00324506Collaborator
Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
PHASE2Completed
43 participants
Started: May 31, 2006 · Completed: Jun 30, 2009
NCT00433186Collaborator
Mycophenolate Mofetil in Systemic Sclerosis
PHASE1Completed
30 participants
Started: Mar 31, 2006 · Completed: Mar 31, 2011
NCT00377637Collaborator
A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.
PHASE3Completed
370 participants
Started: Jul 31, 2005 · Completed: Mar 31, 2010
NCT00683969Collaborator
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
PHASE3Completed
136 participants
Started: Aug 31, 2004 · Completed: May 31, 2007
Locations (1)
Headquarters
Blue Ash, OH, United States
Map
Loading map...